Affect Therapeutics

📍 Remote, United States🗓 Founded 2020👥 86 employees💰 Last funded Jun 2023
Hospitals and Health Care🌐 affecttherapeutics.com
Website LinkedIn
Affect Therapeutics is a nation-wide substance use disorder treatment provider for alcohol, marijuana/cannabis, methamphetamine, cocaine, and prescription stimulants. Our wholistic program is delivered through a revolutionary smartphone app that reduces known barriers in access to care and leverages the latest research and technology to achieve incredible results. We use contingency management and other types of rewards systems as engagement techniques as well as harm reduction to keep people working towards their goals. Designed with behavioral engineering and gamification principles, our app stimulates the brains rewards center as people reduce their use of substances and learn to manage the chronic disease of addiction into remission. Accredited by CARF Internation and supported by NIDA and NIH, Affects revolutionary program and technology achieve outcomes more than double of traditional rehab models. Thousands of people who have struggled to break free of addiction have found success with us. We partner with a wide range of organizations who are working to address the nations addiction crisis. We work with referral partners across the treatment sector to provide the appropriate levels of care for each individual. Affect makes care available to communities that do not have access to clinics and it works in a continuum of care so people leaving detox and inpatient can continue to work their recovery programs conveniently and discreetly. Community organizations and partners in the criminal justice system rely on us to support them. Find out more about how Affect works, how you can work with us, and if it can work for you at our website. Our app is free to download and use. The program is covered by Medicaid and we accept many commercial insurance plans. We beat the deadly game of addiction by changing the rules. Win your life back with Affect.
3
Total investors
1
Early stage
2
Mid stage
0
Late stage
2020
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
United Kingdom
1
Investor activity2022–2023 · investors recorded per year
2022120232
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Affect Therapeutics?
Affect Therapeutics has 3 investors on record on gritt.io, including 1 early-stage backers, 2 mid-stage.
When did Affect Therapeutics last raise funding?
The most recent investment in Affect Therapeutics recorded on gritt.io was in June 2023.
When was Affect Therapeutics founded?
Affect Therapeutics was founded in 2020.
What industry is Affect Therapeutics in?
Affect Therapeutics operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is Affect Therapeutics based?
Affect Therapeutics is headquartered in Remote, United States.